Sanara MedTech (SMTI) Cash from Investing Activities (2010 - 2026)
Sanara MedTech's (SMTI) quarterly Cash from Investing Activities came in at -$43772.0 in Q1 2026, up 99.15% YoY from -$21978.9 in Q1 2025, and up 98.21% on a QoQ basis from -$2.4 million in Q4 2025.
Sanara MedTech (SMTI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 15 years of Cash from Investing Activities data on file, last reported at -$43772.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 99.15% year-over-year to -$43772.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.8 million (up 16.1% YoY) and the FY2025 annual result came in at -$15.0 million, down 126.48% from the prior year.
- Cash from Investing Activities improved to -$43772.0 in Q1 2026, from -$2.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$12945.0 in Q2 2023 to a low of -$10.1 million in Q3 2023.
- A 5-year average of -$2.1 million and a median of -$376954.0 in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 99.38% — and 2025, when it sank 7769.97%.
- Tracing SMTI's Cash from Investing Activities over 5 years: stood at -$376954.0 in 2022, then jumped by 85.6% to -$54276.0 in 2023, then plunged by 139.51% to -$129994.0 in 2024, then slumped by 1781.07% to -$2.4 million in 2025, then surged by 98.21% to -$43772.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$43772.0 (Q1 2026), -$2.4 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,772.00 |
| Mar 31, 2026 | -43,772.00 |
| Dec 31, 2025 | -2.45 Mn |
| Dec 31, 2025 | -2.45 Mn |
| Sep 30, 2025 | -3.42 Mn |
| Sep 30, 2025 | -3.42 Mn |
| Jun 30, 2025 | -3.93 Mn |
| Jun 30, 2025 | -3.93 Mn |
| Mar 31, 2025 | -5.18 Mn |
| Mar 31, 2025 | -5.18 Mn |
| Dec 31, 2024 | -129,994.00 |
| Dec 31, 2024 | -129,994.00 |
| Sep 30, 2024 | -6.36 Mn |
| Sep 30, 2024 | -6.36 Mn |
| Jun 30, 2024 | -58,762.00 |
| Jun 30, 2024 | -58,762.00 |
| Mar 31, 2024 | -65,818.00 |
| Mar 31, 2024 | -65,818.00 |
| Dec 31, 2023 | -54,276.00 |
| Dec 31, 2023 | -54,276.00 |